Circular proteins and their smaller versions, cyclic peptides, have a characteristic head-to-tail or end-to-end peptide backbone structure. The absence of both N and C termini in these macrocycles confers resistance to exopeptidase and heat degradation, enhances their conformational stability, and maximizes epitope display upon their circular contiguous sequences for interactions with other molecules. These advantages have provided incentives to engineer circular proteins by grafting linear bioactive peptides or epitopes into various structural scaffolds for therapeutic applications (1).For the purpose of this minireview, we refer to a cyclic peptide of Ͼ15 amino acids as a "circular protein" or "miniprotein." This arbitrary cutoff point has two justifications. First, many cyclic peptides of Ͻ15 amino acids are derived from nonribosomal synthesis, and the substrate specificity of a cyclase enzyme such as tyrocidine thioesterase could accommodate precursors of 6 -14 amino acids in length (2). Second, circular proteins are gene-encoded and processed by specific enzymes from their linear precursors containing a signal peptide and one or more prodomains (3). Cyclic peptides and circular proteins are frequently found in bacteria (microcin), fungi (cyclosporin), animals (-defensins), and more commonly, plants (cyclotides) (4 -7).From a synthetic standpoint, chemical synthesis of circular proteins has been a formidable challenge using the traditional enthalpic methods, which require partially or globally protected linear precursors and a strong enthalpic activation of the C-terminal residue for the cyclization reaction (Fig. 1A). Strong activation of the C-terminal moiety is necessary to overcome the entropy barrier in the coupling reactions and often leads to epimerization of the C-terminal amino acid residue and oligomerization to dimers and trimers. Work prior to 1997 showcased the challenges associated with enthalpy-driven cyclization of peptides of Ͻ15 amino acids. In 1997, we reported the total synthesis of circular proteins of 31 amino acids, cyclotides circulin B and cyclopsychotride, and in the following year, two other cyclotides (8,9). These studies represented a breakthrough because they were the first reports on a successful chemical synthesis of naturally occurring circular proteins using an entropy-driven ligation chemistry, which is conceptually different and operationally much simpler than the conventional enthalpy cyclization method.Many review articles have been published over the last few years, with a majority articulating the occurrence, chemistry, and biological functions of cyclic peptides (10 -13). Here, we will focus on contemporary entropy-driven ligation chemistry for the synthesis of circular proteins.
Entropy-driven Ligation ChemistryDuring the 1990s, there was a paradigm shift in the synthesis of large peptides and proteins (14 -18). The sea change was driven by the discovery of entropic activation in convergent peptide synthesis using unprotected peptides as building blocks to enable an ...